Business and Commerce
Press release
Lyrus Receives US FDA Approval for Critical UTI Treatment in the US
The U.S. Food and Drug Administration (FDA) has approved Lyrus Life Sciences’s Abbreviated New Drug Application (ANDA) for ‘Methenamine Hippurate Tablets USP, 1 gram‘, an AB-rated, substitutable generic version...
